scholarly journals Ipragliflozin in combination with metformin for the treatment of Japanese patients with type 2 diabetes: ILLUMINATE, a randomized, double-blind, placebo-controlled study

2014 ◽  
Vol 17 (3) ◽  
pp. 304-308 ◽  
Author(s):  
A. Kashiwagi ◽  
K. Kazuta ◽  
K. Goto ◽  
S. Yoshida ◽  
E. Ueyama ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Japanese Patients ◽  
Controlled Study ◽  
Double Blind ◽  
Double Blind Placebo

Efficacy and safety of ipragliflozin as an add-on to pioglitazone in Japanese patients with inadequately controlled type 2 diabetes: a randomized, double-blind, placebo-controlled study (the SPOTLIGHT study)

2014 ◽  
Vol 6 (2) ◽  
pp. 104-116 ◽  
Author(s):  
Atsunori Kashiwagi ◽  
Takanori Shiga ◽  
Noriko Akiyama ◽  
Kenichi Kazuta ◽  
Atsushi Utsuno ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Japanese Patients ◽  
Controlled Study ◽  
Efficacy And Safety ◽  
Double Blind ◽  
Double Blind Placebo

Pharmacokinetic and pharmacodynamic study of ipragliflozin in Japanese patients with type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled study

2014 ◽  
Vol 106 (1) ◽  
pp. 50-56 ◽  
Author(s):  
Takeshi Kadokura ◽  
Noriko Akiyama ◽  
Atsunori Kashiwagi ◽  
Atsushi Utsuno ◽  
Kenichi Kazuta ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Japanese Patients ◽  
Controlled Study ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Pharmacodynamic Study

Initial combination of linagliptin and metformin improves glycaemic control in type 2 diabetes: a randomized, double-blind, placebo-controlled study

2012 ◽  
Vol 14 (6) ◽  
pp. 565-574 ◽  
Author(s):  
T. Haak ◽  
T. Meinicke ◽  
R. Jones ◽  
S. Weber ◽  
M. von Eynatten ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Glycaemic Control ◽  
Controlled Study ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Initial Combination

Monotherapy with the once-weekly GLP-1 analogue dulaglutide for 12 weeks in patients with Type 2 diabetes: dose-dependent effects on glycaemic control in a randomized, double-blind, placebo-controlled study

2012 ◽  
Vol 29 (10) ◽  
pp. 1260-1267 ◽  
Author(s):  
G. Grunberger ◽  
A. Chang ◽  
G. Garcia Soria ◽  
F. T. Botros ◽  
R. Bsharat ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Glycaemic Control ◽  
Controlled Study ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Dose Dependent

Treatment with omega-3 polyunsaturated fatty acids does not improve endothelial function in patients with type 2 diabetes and very high cardiovascular risk: A randomized, double-blind, placebo-controlled study (Omega-FMD)

2018 ◽  
Vol 271 ◽  
pp. 148-155 ◽  
Author(s):  
Aleksander Siniarski ◽  
Maciej Haberka ◽  
Magdalena Mostowik ◽  
Renata Gołębiowska-Wiatrak ◽  
Małgorzata Poręba ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Fatty Acids ◽  
Cardiovascular Risk ◽  
Controlled Study ◽  
Omega 3 ◽  
High Cardiovascular Risk ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Very High
Sign in / Sign up

Export Citation Format

Share Document